Preliminary
Clinical Translation — Clinical trials, drug repurposing, regulatory pathways, and geroprotectors in humans
Other
medRxiv
Tests whether transfusing young blood plasma could slow memory loss in early Alzheimer's disease in humans.
First human feasibility study directly mimicking heterochronic parabiosis via large-volume young plasma exchange in AD patients; demonstrates procedural safety but lacks efficacy data or mechanistic validation.
Researchers tested whether replacing a patient's blood plasma with plasma from young, healthy donors could slow cognitive decline in early Alzheimer's disease. In 12 patients, the procedure proved safe and feasible, though this early-stage study …
medrxiv (preprint)